Trial | NCT01025934  Report issue

Official Title

Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    bevacizumab ...

  • Study Participants

    None
The purpose of this study is to evaluate the role, the safety and the effectiveness of Intravitreal Bevacizumab injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy.
Study Started
Dec 03
2009
Last Update
Dec 04
2009
Estimate

Drug Bevacizumab

Other sham

7 days Active Comparator

20 days Active Comparator

sham Sham Comparator

Criteria 

Inclusion Criteria:

vitreous haemorrhage
tractional retinal detachment
active proliferative diabetic retinopathy.

Exclusion Criteria:

neovascular glaucoma
cataract
combined traction and rhegmatogenous RD
No Results Posted